-+ 0.00%
-+ 0.00%
-+ 0.00%

Phio Pharma wins US, Canada patent allowances for INTASYL siRNA compounds

PUBT·07/15/2026 11:04:40
Listen to the news
Phio Pharma wins US, Canada patent allowances for INTASYL siRNA compounds
  • Phio Pharmaceuticals reported three notices of allowance in the US and Canada for patents covering INTASYL siRNA compounds.
  • A separate patent grant decision was received in Japan, strengthening protection for the same INTASYL technology.
  • Phio’s global patent portfolio totals 54 issued patents spanning INTASYL chemistry, gene targets, and immuno-oncology indications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607150700NEWSFILECNPR____20260715_305218_1) on July 15, 2026, and is solely responsible for the information contained therein.